Ganciclovir

Kathryn Dzintars, Pharm.D. BCPS, Paul A. Pham, Pharm.D., Alice Jenh Hsu, Pharm.D.
Ganciclovir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of CMV retinitis (IV) in immunocompromised pts.
  • Prophylaxis and prevention of CMV disease recurrence in pts with AIDS and solid organ transplant recipients (use for primary prophylaxis in HIV is FDA approved but not currently recommended; valganciclovir preferred).
  • Herpes keratitis (ophthalmic gel)

NON-FDA APPROVED USES

  • Castleman’s disease (limited data)

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: April 11, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Ganciclovir ID - 545262 A1 - Dzintars,Kathryn,Pharm.D. BCPS AU - Pham,Paul,Pharm.D. AU - Hsu,Alice,Pharm.D. Y1 - 2017/04/11/ PB - Johns Hopkins HIV Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545262/all/Ganciclovir ER -